Improvement of some pharmaceutical properties of mycophenolate mofetil (MMF) by para sulphonatocalix[4]resorcinarene inclusion complex

  • Shobhana K. MenonEmail author
  • Nishith R. Modi
  • Bhoomika Mistry
  • Kuldeep Joshi
Original Article


As a part of our investigations to unfold the chemistry of calixresorcinarene, we have focused on the formation of inclusion complex of a poorly soluble (43 μg ml−1 at pH 7) drug mycophenolate mofetil (MMF) an immunosuppressive agent and an inosine monophosphate dehydrogenase (IMPDH) inhibitor with para sulphonatocalix[4]resorcinarene (PSC4R). The complete complexation of the drug was achieved after 48 h of stirring with para sulphonatocalix[4]resorcinarene(PSC[4]R) in water and evaporation of water yield the solid complex. The interaction between para sulphonatocalix[4]resorcinarene(PSC[4]R) and MMF in solid state inclusion complexes was accomplished by aqueous phase solubility studies, Thermal Analysis, HPLC, PXRD, FT-IR, and UV–Vis spectroscopy. The results of the phase solubility experiments are in good conformity to signify the formation of 2:1 PSC4R: MMF complexes. The purpose of this study was to enhance solubility and resulting in high dissolution rate and bioavailability of this essentially water insoluble drug. The results of the in vivo study shows that there is a remarkable change in the toxicity of the pure drug MMF and complex did not produce any mortality up to 2200 mg kg−1.


Para sulphonatocalix[4]resorcinarene MMF Phase solubility study In vitro release Acute toxicity Inclusion complex 



Financial assistance from UGC, New Delhi and CDRI, Lucknow for spectral analysis is gratefully acknowledged.


  1. 1.
    Mutihac, L.: Functionalized Calix[n]arenes as membrane transporters for biological compounds. Curr. Drug Discov. Technol. 5, 98–104 (2008)CrossRefGoogle Scholar
  2. 2.
    Iwanek, W., Wzorek, A.: Introduction to the chirality of resorcinarenes. Mini-Rev. Org. Chem. 6, 398–411 (2009)CrossRefGoogle Scholar
  3. 3.
    Shivanyuk, A.: Nanoencapsulation of Calix[4]arene inclusion complexes. J. Am. Chem. Soc. 129(46), 14196–14199 (2007)CrossRefGoogle Scholar
  4. 4.
    Panchal, J., Patel, R., Menon, S.: Preparation and physicochemical characterization of carbamazepine (CBMZ): para-sulfonated Calix[n]arene inclusion complexes. J. Incl. Phenom. Macrocycl. Chem. doi: 10.1007/s10847-009-9698-3
  5. 5.
    Saxena, S., Virmani, S., Singh, K., Malhotra, K.K.: Mycophenolate mofetil in the treatment of nephrotic syndrome. Indian J. Nephrol. 14, 15–17 (2004)Google Scholar
  6. 6.
    Cornberg, M., Hinrichsen, H., Teuber, G., Berg, T., Naumann, U., Falkenberg, C., Zeuzem, S., Manns, M.P.: Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C. J. Hepatol. 37(6), 843–847 (2002)CrossRefGoogle Scholar
  7. 7.
    Tsai, Y., Tsai, H.H., Wu, C.P., Tsai, F.J.: Preparation, characterisation and activity of the inclusion complex of paeonol with b-cyclodextrin. Food Chem. 120, 837–841 (2010)CrossRefGoogle Scholar
  8. 8.
    Wen, X.H., Tan, F., Jing, Z., Liu, Z.: Preparation and study the 1:2 inclusion complex of carvedilol with cyclodextrin. J. Pharm. Biomed. Anal. 34, 517–523 (2004)CrossRefGoogle Scholar
  9. 9.
    Zhao, M., Wang, H., Yang, B., Tao, H.: Identification of cyclodextrin inclusion complex of chlorogenic acid and its antimicrobial activity. Food Chem. 120, 1138–1142 (2010)CrossRefGoogle Scholar
  10. 10.
    Loftssona, T., Duchêneb, D.: Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329(1–2), 1–11 (2007)CrossRefGoogle Scholar
  11. 11.
    Carrier, R.L., Miller, L.A., Ahmed, I.: The utility of cyclodextrins for enhancing oral bioavailability. J. Control Release 123(2), 78–99 (2007)CrossRefGoogle Scholar
  12. 12.
    Hashimoto, H.: Present status of industrial application of cyclodextrins in Japan. J. Incl. Phenom. Macroc. Chem. 44, 57–62 (2003)CrossRefGoogle Scholar
  13. 13.
    Perrone, D., Farah, A., Donangelo, C.M., de Paulis, T., Martin, P.R.: Comprehensive analysis of major and minor chlorogenic acids and lactones in economically relevant Brazilian coffee cultivars. Food Chem. 106, 859–867 (2008)CrossRefGoogle Scholar
  14. 14.
    Timmerman, P., Verboom, W., Reinhoudt, D.N.: Resorcinarenes. Tetrahedron 52, 2663–2704 (1996)CrossRefGoogle Scholar
  15. 15.
    Tunstad, L.M., Tucker, J.A., Dalcanale, E., Weiser, J., Bryant, J.A., Sherman, J.C., Helgeson, R.C., Knobler, C.B., Cram, D.J.: Host-guest complexation. 48. Octol building blocks for cavitands and carcerands. J. Org. Chem. 54, 1305–1312 (1989)CrossRefGoogle Scholar
  16. 16.
    Kazakova, E.K., Makarova, N., Zoganshina, A., Muslinkina, L., Muslinkin, A., Habicher, W.: Novel water soluble tetra sulfonatomethyl calix[4]resorcinarenes. Tetrahedron Lett. 41, 10111–10115 (2000)CrossRefGoogle Scholar
  17. 17.
    The United States Pharmacopeia, XXIV edn. United States Pharmacopeial Convention Inc., Rockville, USA (2000)Google Scholar
  18. 18.
    Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117–212 (1965)Google Scholar
  19. 19.
    Ghorab, M., Adeyeye, M.C.: Elucidation of solution state complexation in wet-granulated oven-dried ibuprofen and b-cyclodextrin: FT-IR and 1H-NMR studies. Pharm. Dev. Tech. 6, 315–324 (2001)CrossRefGoogle Scholar
  20. 20.
    Rustichelli, C., Gamberini, G., Ferioli, V., Gamberini, M.C., Ficarra, R., Tommasini, S.: Solid-state study of polymorphic drugs: carbamazepine. J. Pharm. Biomed. Anal. 23, 41–54 (2000)CrossRefGoogle Scholar
  21. 21.
    Eugene, F.F., Timothy, A.H., Lachmann, I., Liberman, H.A., Kanig, J.L.: The Theory and Practice of Industrial Pharmacy, vol. 3, p. 171. Varghese Publishing House, Mumbai (1987)Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Shobhana K. Menon
    • 1
    Email author
  • Nishith R. Modi
    • 1
  • Bhoomika Mistry
    • 1
  • Kuldeep Joshi
    • 1
  1. 1.Department of Chemistry, School of SciencesGujarat University, NavrangpuraAhmedabadGujaratIndia

Personalised recommendations